Work

CD123 bi-specific antibodies in development in AML: What do we know so far?

Year: 2020

Type: review

Source: Best Practice & Research Clinical Haematology

DOI: 10.1016/j.beha.2020.101219

Authors: Michael J. Slade, Geoffrey L. Uy

Institution: Washington University in St. Louis

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Astellas Pharma, Genentech

OpenAlex ID: W3095448915

FWCI: 0.471

Cites: 51

Cited by: 15

Related to: 10